CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($) $ in Thousands	Total	Cumulative Effect, Period of Adoption, Adjustment	Related Party	Nonrelated Party	Preferred Stock	Common Stock	Common Stock Related Party	Common Stock Nonrelated Party	Additional Paid-in Capital	Additional Paid-in Capital Related Party	Additional Paid-in Capital Nonrelated Party	Treasury Stock	Accumulated Deficit	Accumulated Deficit Cumulative Effect, Period of Adoption, Adjustment
Beginning balance, preferred (in shares) at Dec. 31, 2022					9,566
Beginning balance at Dec. 31, 2022	$ 117,754				$ 9,273	$ 145			$ 294,810			$ 0	$ (186,474)
Beginning balance (in shares) at Dec. 31, 2022						145,492,971
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common stock reacquired in exchange for warrants (in shares)						(12,000,000)
Common stock reacquired in exchange for warrants	12,491					$ 12			12,479
Warrant issuance in conjunction with debt modification	16,036								16,036
Warrant offerings	14,991								14,991
Warrant exercise (in shares)						25,871,539
Warrant exercise	3,527					$ 27			3,500
Conversion of preferred stock to common stock (in shares)						11,762,956
Conversion of preferred stock to common stock	4,705					$ 12			4,693
Common stock offering, net of issuance costs (in shares)						99,136,670
Common stock offering, net of issuance costs	$ 132,542					$ 98			132,444
Common stock issued for share based liabilities due to related party & stock-based compensation expense and issuance of stock (in shares)							2,460,513	5,586,736
Common stock issued for share based liabilities due to related party & stock-based compensation expense and issuance of stock			$ 15,000	$ 5,859			$ 2	$ 5		$ 14,998	$ 5,854
Tax withholdings related to net share settlements of stock-based compensation awards (in shares)	(1,578,056)					(1,578,056)
Tax withholdings related to net share settlements of stock-based compensation awards	$ (2,013)								(2,013)
Net loss	(73,421)												(73,421)
Ending balance, preferred (in shares) at Dec. 31, 2023					9,566
Ending balance at Dec. 31, 2023	222,489	$ 37			$ 9,273	$ 277			472,834			0	(259,895)	$ 37
Ending balance (in shares) at Dec. 31, 2023						276,733,329
Beginning balance, preferred (in shares) at Dec. 31, 2023					9,566
Beginning balance at Dec. 31, 2023	222,489	$ 37			$ 9,273	$ 277			472,834			0	(259,895)	$ 37
Beginning balance (in shares) at Dec. 31, 2023						276,733,329
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Warrant exercise (in shares)						31,853,909
Warrant exercise	4,808					$ 32			4,776
Common stock offering, net of issuance costs (in shares)			1,083,189			67,368,125
Common stock offering, net of issuance costs	189,213		$ 2,500			$ 67			189,146
Common stock issued for share based liabilities due to related party & stock-based compensation expense and issuance of stock (in shares)							1,083,189	12,241,621
Common stock issued for share based liabilities due to related party & stock-based compensation expense and issuance of stock			$ 2,500	30,927			$ 1	$ 7		2,499	30,920
Common stock issued for new ground lease to related party (in shares)						20,000,000
Common stock issued for new ground lease to related party	68,760					$ 20			68,740
Purchase of capped call	(60,000)								(60,000)
Treasury stock repurchased	$ (118,217)											(118,217)
Tax withholdings related to net share settlements of stock-based compensation awards (in shares)	(5,057,145)					(5,057,145)
Tax withholdings related to net share settlements of stock-based compensation awards	$ (23,654)								(23,654)
Net loss	$ (72,418)												(72,418)
Ending balance, preferred (in shares) at Dec. 31, 2024	9,566				9,566
Ending balance at Dec. 31, 2024	$ 244,445				$ 9,273	$ 404			685,261			(118,217)	(332,276)
Ending balance (in shares) at Dec. 31, 2024	385,654,278					404,223,028
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Warrant exercise (in shares)						6,166,231
Warrant exercise	$ 5,686					$ 6			5,680
Conversion of preferred stock to common stock (in shares)					9,566	1,356,738
Conversion of preferred stock to common stock	(12)				$ 9,273	$ 1			9,260
Common stock offering, net of issuance costs (in shares)			798,319			18,554,688
Common stock offering, net of issuance costs	110,293					$ 19			110,274
Common stock issued for share based liabilities due to related party & stock-based compensation expense and issuance of stock (in shares)							798,319	10,033,634
Common stock issued for share based liabilities due to related party & stock-based compensation expense and issuance of stock			$ 2,375	$ 50,909			$ 1	$ 5		$ 2,374	$ 50,904
Common stock issued as consideration for business acquisition (in shares)						7,968,852
Common stock issued as consideration for business acquisition	39,347					$ 8			39,339
2031 Convertible Notes conversion feature	511,191								511,191
Purchase of capped call	(100,600)								(100,600)
Treasury stock repurchased	$ (33,292)											(33,292)
Tax withholdings related to net share settlements of stock-based compensation awards (in shares)	(4,566,796)					(4,566,796)
Tax withholdings related to net share settlements of stock-based compensation awards	$ (28,481)								(28,481)
Net loss	$ (661,416)												(661,416)
Ending balance, preferred (in shares) at Dec. 31, 2025	0				0
Ending balance at Dec. 31, 2025	$ 140,445				$ 0	$ 444			$ 1,285,202			$ (151,509)	$ (993,692)
Ending balance (in shares) at Dec. 31, 2025	420,065,944					444,534,694